About Ronald Sayco
Form D filings for S1P Therapeutics in 2023 list Ronald Sayco as chief executive officer and director.
Ronald Sayco first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ronald Sayco in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ronald Sayco works with at each company, as listed on that company's latest Form D.
S1P Therapeutics Inc. · Form D, Jun 9, 2023
KL
Kevin Lynch
Executive officer and director
WS
Webster Santos
Executive officer and director